• Directory
  • Search
  • All results
  • Journals
  • Definitions
Immunologic Factor
lintuzumab
Definitions related to lintuzumab:
  • A humanized recombinant monoclonal antibody directed against CD33, a cell surface antigen found on myeloid leukemia blasts and early hematopoietic progenitor cells. Lintuzumab stimulates antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells expressing CD33, resulting in a decrease in tumor burden. The humanized version of this monoclonal antibody exhibits less immunogenicity and improved binding affinity compared to its murine counterpart.
    NCI
    U.S. National Cancer Institute, 2021
  • A substance being studied in the treatment of myelodysplastic syndromes and some types of leukemia. It binds to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. It causes the immune system to kill these cells. Lintuzumab is a type of monoclonal antibody.
    NCI Dictionary of Cancer Terms
    U.S. National Cancer Institute, 2021
Return to OpenMD Medical Dictionary > L
Try this search on: Farlex, Merriam-Webster, Oxford Dictionary, or Wordnik

This content should not be used in place of medically-reviewed decision support reference material or professional medical advice. Some terms may have alternate or updated definitions not reflected in this set. The definitions on this page should not be considered complete or up to date.

  • About
  • Feedback
  • Guides
  • Terms
© 2026 OpenMD
The content on this site is NOT a substitute for professional medical advice or diagnosis. Always seek the advice of your doctor or health care provider.